Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Sep;38(9):2541-2546.
doi: 10.1007/s10067-019-04536-y. Epub 2019 Apr 24.

Malar Rash Is a Predictor of Subclinical Airway Inflammation in Patients With Systemic Lupus Erythematosus: A Pilot Study

Multicenter Study

Malar Rash Is a Predictor of Subclinical Airway Inflammation in Patients With Systemic Lupus Erythematosus: A Pilot Study

Giovanni Damiani et al. Clin Rheumatol. .


Background: Systemic lupus erythematosus (SLE) is a chronic, auto-immune, multi-organ disease that can affect both the skin and the lungs. Malar rash is a common skin manifestation of SLE and is linked to SLE disease activity, whereas lung involvement is a generally negative prognostic factor for these patients. However, a sensitive and non-invasive screening tool for potential lung involvement in SLE patients is still not available.

Methods: This study aimed to investigate the relationship between malar rash and airway inflammation in adult SLE patients who were not known to have any lung involvement (clinical or radiologic). The study comprised of the measurement of the concentration of NO in exhaled breath or fraction of exhaled nitric oxide (FeNO) and levels were compared between those with and without malar rash. This tool is considered as a sensitive and non-invasive method that is routinely used in patients with asthma or other respiratory diseases to identify airway inflammation.

Results: A total of 125 patients (100 females, 25 males) were enrolled during the study period from January 2011 to December 2014. Patients with malar rash (N = 35) had a significant decrease in serum levels of C4 (p < 0.05) compared to patients without malar rash (N = 90). The mean levels of FeNO in overall patients were 36.44 ± 8.87 ppb. A statistically significant difference in FeNO50 values between patients with malar rash (43.46 ± 6.72 ppb) and without (29.43 ± 3.64 ppb) was found (p < 0.001). FeNO50 values were inversely correlated only with serum C4 (p < 0.01). However, no correlation between FeNO50 values and SLE clinical disease activity scores was found.

Conclusions: The presence of a malar rash may predict sub-clinical airway inflammation in SLE patients. Further prospective studies are needed to confirm the usefulness of FeNO measurements in monitoring SLE-associated airway inflammation.

Keywords: Airway inflammation; FeNO; LFA-REAL; Malar rash; Systemic lupus erythematosus.

Similar articles

See all similar articles


    1. Chest. 2006 Nov;130(5):1541-6 - PubMed
    1. Lupus. 2008 May;17(5):389-93 - PubMed
    1. Ann Rheum Dis. 2011 Oct;70(10):1752-7 - PubMed
    1. Am J Respir Crit Care Med. 2011 Sep 1;184(5):602-15 - PubMed
    1. Arthritis Rheum. 2012 Aug;64(8):2677-86 - PubMed

Publication types

LinkOut - more resources